Physician profile
Caleb Nunley
NPI 1427256940
$735.78
in general payments reported to CMS, 2019-2025
10 companies · $68.74 in 2025
The $68.74 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $83.27 · 2021: $48.10 · 2022: $76.04 · 2023: $272 · 2024: $52.81 · 2025: $68.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $269.51 | 2019-2023 | |
| Pacira Therapeutics, INC. | $167.09 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $107.49 | 2022-2025 | Zilretta, Exparel, Iovera |
| Bioventus LLC | $84.17 | 2022-2025 | Exogen Ultrasound Bone Healing System, Durolane, Durolane |
| Horizon Therapeutics Plc | $23.81 | 2022 | |
| Pylant Medical | $23.43 | 2023 | |
| Pfizer INC. | $16.19 | 2020 | |
| Zyla Life Sciences, INC. | $15.04 | 2019 | |
| Depuy Synthes Sales INC. | $14.82 | 2024 | Monovisc |
| Avanos Medical | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Nunley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.